Aquestive Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -8.94M-61.38M-66.25M-55.78M-70.54M-54.41M-7.87M-44.14M
Depreciation and Depletion 3.19M2.85M3.39M2.91M2.27M1.15M0.64M
Share-based Compensation 29.94M7.07M6.58M6.82M4.38M2.69M7.10M
Gains from Sales and Divestitures 0.06M0.12M0.06M
Gains from Investment Securities 1.12M2.90M1.70M0.70M0.30M0.05M0.20M1.10M
Asset Writedowns and Impairment 0.05M
Non-cash Items 0.09M0.40M1.24M
Cash from Operations 5.82M-12.99M-60.21M-45.46M-32.98M-9.82M-6.38M-35.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.12M0.13M
Amortization of Deferred Charges 1.86M1.70M1.93M2.59M3.73M0.21M1.97M10.71M
Depreciation & Amortization (CF) 3.75M3.24M2.90M3.44M2.96M2.39M1.34M0.72M
Change in Working Capital
Change in Receivables -4.69M0.41M6.82M-6.17M5.35M-7.35M3.07M-1.09M
Change in Inventory 1.13M1.43M-2.58M-0.40M1.58M1.74M0.99M-0.72M
Change in Account Payables 2.94M11.32M-7.87M-5.18M1.23M1.63M-1.02M2.78M
Change in Accured Expenses 1.00M0.28M0.75M2.98M-0.84M-2.38M-2.52M-1.49M
Investing Activities
Capital Expenditures 2.07M1.82M0.66M0.52M0.91M1.02M0.99M0.16M
Change in Intangibles 1.50M
Cash from Investing Activities -2.07M-1.82M-0.66M-0.52M-0.91M-2.52M-0.99M-0.16M
Financing Activities
Other financing activities 0.61M4.77M3.95M2.91M4.64M
Debt Issuance and Repayment
Long-Term Debt Issuances 5.00M70.00M50.00M31.14M
Long-Term Debt Repayments 50.00M22.50M51.53M0.02M
Short-Term Debt issuances 0.68M
Change in Capital Stock
Shares Issued 0.02M68.83M39.32M6.21M0.18M0.03M0.04M0.73M
Misc.
Cash from Financing Activities 4.41M58.03M49.60M28.46M30.11M11.59M3.97M83.59M
Change in Cash 8.17M43.22M-11.27M-17.52M-3.78M-0.75M-3.40M47.67M
Beginning Cash Balance 9.21M17.38M60.60M49.33M31.81M28.02M27.27M23.87M
Free Cash Flow 3.76M-14.81M-60.87M-45.98M-33.89M-10.84M-7.38M-35.92M
Net Cash Flow 8.17M43.22M-11.27M-17.52M-3.78M-0.75M-3.40M47.67M